PBTC-033 – Summary for Patients and Families Title: PBTC-033 A Phase I II Study of ABT-888, an Oral Poly( ADP-ribose) Polymerase Inhibitor, and Concurrent Radiation Therapy, Followed by ABT-888 and Temozolomide, in Ch - Brainstem glioma - Document - PDFSEARCH.IO

First Page	Meta Content
	PBTC-033 – Summary for Patients and Families Title: PBTC-033 A Phase I/ II Study of ABT-888, an Oral Poly( ADP-ribose) Polymerase Inhibitor, and Concurrent Radiation Therapy, Followed by ABT-888 and Temozolomide, in Ch Add to Reading List Document Date: 2011-11-30 13:32:37 Open Document File Size: 119,27 KB Share Result on Facebook Country United States / / / IndustryTerm cancer care / diffusion tensor imaging / / MedicalCondition tumor / cancer / tumors / disease / brainstem tumor / glioblastoma multiforme / glioma / Nausea / anaplastic mixed glioma / vomiting / routine cancer / gliosarcoma / brainstem tumors / inflammation / Newly Diagnosed Diffuse Pontine Gliomas / brain tumor / Brain tumors / either anaplastic astrocytoma / / MedicalTreatment radiation treatment / radiation therapy / chemotherapy / surgery / radiation / / Organization National Cancer Institute / Pediatric Hematology-Oncology Texas Children’s Cancer Center / PBTC / Cancer Information Service / / Person Patricia A. Baxter / / / Product pseudo / / Technology Radiation / chemotherapy / MRI / / URL www.cancer.gov / www.cancernet.org / / SocialTag Temozolomide Glioma PARP inhibitor Radiation therapy Magnetic resonance imaging Chemotherapy Breast cancer treatment Brainstem glioma Medicine Brain tumor

PBTC-033 – Summary for Patients and Families Title: PBTC-033 A Phase I/ II Study of ABT-888, an Oral Poly( ADP-ribose) Polymerase Inhibitor, and Concurrent Radiation Therapy, Followed by ABT-888 and Temozolomide, in ChAdd to Reading List